2005
DOI: 10.1016/j.jmb.2005.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Guilty by Association: Some Collagen II Mutants Alter the Formation of ECM as a Result of Atypical Interaction with Fibronectin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
63
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 34 publications
(67 citation statements)
references
References 47 publications
4
63
0
Order By: Relevance
“…Mutations in type II collagen result in abnormal deposition of both type II collagen and fibronectin. In this study, impaired fibronectin assembly was attributed to alterations in fibronectin interactions caused by its binding to thermally labile collagen II mutant (38). It is not known why cells lacking type I collagen are defective in fibronectin matrix deposition (23), whereas disruption of fibronectin-collagen binding due to a mutation in fibronectin or the presence of blocking peptides does not disrupt fibronectin matrix deposition or stability (Figs.…”
Section: Discussionmentioning
confidence: 74%
“…Mutations in type II collagen result in abnormal deposition of both type II collagen and fibronectin. In this study, impaired fibronectin assembly was attributed to alterations in fibronectin interactions caused by its binding to thermally labile collagen II mutant (38). It is not known why cells lacking type I collagen are defective in fibronectin matrix deposition (23), whereas disruption of fibronectin-collagen binding due to a mutation in fibronectin or the presence of blocking peptides does not disrupt fibronectin matrix deposition or stability (Figs.…”
Section: Discussionmentioning
confidence: 74%
“…In brief, procollagen I at a concentration 230 g/ml was digested with Lys-C (1 g/ml) for 0.5 h at 25°C, experimental conditions in which formation of collagen fibrils does not occur (21). After initial incubation, a possible enzymatic digestion of Lys-C-sensitive antibodies was inhibited by N␣-p-tosyl-L-lysine chloromethyl ketone (TPCK, Sigma-Aldrich) added to a final concentration of 1 mM (19,22). Subsequently, the anti-␣2Ct antibody was added to the Lys-C-processed collagen samples at concentrations of 180 or 10 g/ml to achieve collagen/antibody molar ratios of about 1:2 or 10:1, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…[3] Any alterations of FN conformation caused by binding of FN ligand/s, and/or by posttranslation modifications, including its fragmentation by proteases, [11−13] has been reported to disturb FN domain arrangement, can alter tissue architecture, affecting biological activities and cellular communication, and can lead in turn to tissue dysfunctions. [2,4−6] FN has an ability to form crosslinked high-molecular complexes with FN fragments, [11−13] various extracellular matrix, [14] and some blood plasma components including fibrin. [15,16] During blood clotting transglutaminase XIII a catalyzes cross-linking of plasma FN to the fibrin clot via an isopeptide bond.…”
Section: Identification Of Soluble Supramolecular Fn-fibrin Complexesmentioning
confidence: 99%